LRMR
Larimar Therapeutics Inc.
$3.56
+$0.19(+5.64%)
39
Overall
60
Value
18
Tech
--
Quality
Market Cap
$292.72M
Volume
1.15M
52W Range
$1.61 - $6.91
Target Price
$16.70
EPS Estimates Overview
| Current Quarter | $-0.43 | Next Quarter | $-0.43 |
| Current Year | $-1.89 | Next Year | $-1.75 |
| QoQ Growth | +0.0% | YoY Growth | +7.4% |
| 3Y EPS CAGR | +23.5% | Target Price | $16.70 |
| Consensus | Buy | Upside | +369.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LRMR | $3.56 | +5.6% | 1.15M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Larimar Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW